Schedule of Sales and Operating Income by Operating Segment, Excluding Discontinued Operations |
Revenue and operating income (loss) from continuing operations by operating segment are shown in the table below: | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended | | Six Months Ended | | July 4, 2021 | | July 5, 2020 | | July 4, 2021 | | July 5, 2020 | | (In thousands) | Discovery & Analytical Solutions | | | | | | | | Product revenue | $ | 318,085 | | | $ | 225,617 | | | $ | 585,340 | | | $ | 440,973 | | Service revenue | 194,744 | | | 165,385 | | | 382,098 | | | 348,424 | | Total revenue | 512,829 | | | 391,002 | | | 967,438 | | | 789,397 | | Operating income from continuing operations | 64,155 | | | 39,430 | | | 107,102 | | | 67,943 | | Diagnostics | | | | | | | | Product revenue | 449,674 | | | 375,889 | | | 993,971 | | | 586,062 | | Service revenue | 265,968 | | | 44,827 | | | 574,751 | | | 88,655 | | Total revenue | 715,642 | | | 420,716 | | | 1,568,722 | | | 674,717 | | Operating income from continuing operations | 286,280 | | | 160,300 | | | 727,747 | | | 189,891 | | Corporate | | | | | | | | Operating loss from continuing operations | (17,947) | | | (24,091) | | | (34,585) | | | (37,513) | | Continuing Operations | | | | | | | | Product revenue | 767,759 | | | 601,506 | | | 1,579,311 | | | 1,027,035 | | Service revenue | 460,712 | | | 210,212 | | | 956,849 | | | 437,079 | | Total revenue | 1,228,471 | | | 811,718 | | | 2,536,160 | | | 1,464,114 | | Operating income from continuing operations | 332,488 | | | 175,639 | | | 800,264 | | | 220,321 | | Interest and other expense (income), net (see Note 5) | 6,431 | | | 10,812 | | | (6,275) | | | 20,805 | | Income from continuing operations before income taxes | $ | 326,057 | | | $ | 164,827 | | | $ | 806,539 | | | $ | 199,516 | |
|